MedPath

Clinical Efficacy of In-situ Thrombolysis in Case of Intraventricular Haemorraghia by Aneurysm Rupture

Phase 2
Completed
Conditions
Aneurysm, Ruptured
Subarachnoid Hemorrhage
Registration Number
NCT00823485
Lead Sponsor
Centre Hospitalier Universitaire de Nice
Brief Summary

The purpose of this study is to determine the impact of in situ fibrinolysis on the mortality at 30 days in case of subarachnoid hemorrhage.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
19
Inclusion Criteria
  • subarachnoid hemorrhage by aneurysm rupture
  • severe intraventricular hemorraghia
Exclusion Criteria
  • pregnant women
  • hemostasis disturbance

Study & Design

Study Type
INTERVENTIONAL
Study Design
FACTORIAL
Primary Outcome Measures
NameTimeMethod
assessment of mortalityat 30 days
Secondary Outcome Measures
NameTimeMethod
assessment of morbidityat 6 months

Trial Locations

Locations (1)

Neurosurgery department , Nice University Hospital

🇫🇷

Nice, France

Neurosurgery department , Nice University Hospital
🇫🇷Nice, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.